glp 6 in 1 liquid GLP-1 therapies are powerful, but they come with real risks that are often overlooked. Reduced appetite can lead to dehydration and malnutrition if patients are not properly supported, especially clinical trial What to know about GLP-1

B., Gorospe, M

While the pill helped patients lose roughly 11% of their body weight during the clinical trial period, thats still lower than the shot form Wegovy, according to Morgan Stanley analysts

Aerobic fitness, resistance training, balance, coordination, and muscle preservation all matter

It is knowing which patient needs a GLP-1 and which one needs a workup, how to titrate through the nausea window without losing the patient, how to protect lean mass during rapid loss, how to screen for the contraindications that matter, and how to tell a patient honestly what an adjunct will and will not do for them

However, whether TMAO plays a role in this has not been reported thus far and merits further investigation

10.1038/s41591-024-03453-1 346 NusratS.GulickE.LevinthalD.BielefeldtK